Loading
If this is the first time anyone has visited this substance, we may be fetching live data from TGA Product Information, PBS, and state framework sources — that can take up to a minute. Cached substances load in a second or two.
Cabazitaxel, sold under the brand name Jevtana, is a semi-synthetic derivative of a natural taxoid. It is a microtubule inhibitor, and the fourth taxane to be approved as a cancer therapy.[citation needed]
Read the full article on WikipediaCastration resistant metastatic carcinoma of the prostate Clinical criteria: The treatment must be in combination with prednisone or prednisolone, AND The condition must be resistant to treatment with docetaxel; OR Patient must have a documented intolerance necessitating permanent treatment withdrawal or a contraindication to docetaxel, AND The treatment must not be used in combination with a novel hormonal drug, AND Patient must have a WHO performance status of 2 or less, AND Patient must not receive PBS-subsidised cabazitaxel if progressive disease develops while on cabazitaxel.
“Taxanes enhance microtubule stabilization and inhibit cellular mitosis and division. Moreover, taxanes prevent androgen receptor (AR) signaling by binding cellular microtubules and the microtubule-associated motor protein dynein, thus averting AR nuclear translocation.”
A plain-language summary of the cited sources below. Informational only — not medical advice.
Cabazitaxel: Plain-language explainer for family/guardians
What is cabazitaxel? Cabazitaxel is a chemotherapy medicine. It belongs to a group of cancer drugs called taxanes.
What is it used for? Doctors use cabazitaxel to treat metastatic castration-resistant prostate cancer. In plain language: - Metastatic means the prostate cancer has spread beyond the prostate. - Castration-resistant means the cancer is still growing even though the body’s testosterone has been lowered by hormone treatment.
How does it work? Cabazitaxel works in two main ways:
1. It interferes with cell division. Cells have internal structures called microtubules, which act like scaffolding and tracks. Cancer cells need these structures to divide and grow. Cabazitaxel makes microtubules too stable, so cancer cells cannot divide properly.
2. It helps block prostate cancer growth signals. Prostate cancer can be driven by androgen receptors—proteins that respond to male hormones. Normally, these receptors must move into the cell’s nucleus to send growth signals. Cabazitaxel helps prevent that movement, so the growth signal is reduced.
What does this mean for family and guardians? Cabazitaxel is a specialist cancer treatment given by a healthcare team. Because it affects cell division, it can also affect some normal cells, so the care team will monitor the person closely and explain what side effects to watch for. Family members should follow the treating team’s instructions about appointments, blood tests, and safety precautions.
This explainer is general information and does not replace advice from the treating cancer team.
A plain-language summary of the cited sources below. Informational only — not medical advice.
Clinical Summary — Cabazitaxel (taxane)
Cabazitaxel is a taxane indicated for castration-resistant metastatic carcinoma of the prostate. Its mechanism is dual in framing: taxanes enhance microtubule stabilization and inhibit cellular mitosis and division; additionally, they bind cellular microtubules and the microtubule-associated motor protein dynein, preventing androgen receptor (AR) nuclear translocation and thereby averting AR signaling.